Expression of κ-opioid receptor mRNA in human peripheral blood lymphocytes and the relationship between its expression and the inflammatory changes in rheumatoid arthritis

Rheumatology International

Volumn 19, Issue 3, 2000, Pages 95-100

  Gunji, N ^a   Nagashima, M ^a   Asano, G ^a   Yoshino, S ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Lymphocytes; NKcells; Rheumatoid arthritis; RT PCR; opioid receptor mRNA

Indexed keywords

KAPPA OPIATE RECEPTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MACROPHAGE; MALE; NATURAL KILLER CELL; NOCICEPTION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 0034085986     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960050110     Document Type: Article

References (35)

1. 1. Nagashima M, Yoshino S, Ishiwata T, Asano G (1995) Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 22: 1625-1630
2. 2. Atcheson R, Lambert DG (1994) Update on opioid receptors. Br J Anaesth 73: 132-134
3. 3. Loh HH, Smith AF (1990) Molecular characterization of opioid receptors. Pharmacol Toxicol 30: 123-147
4. 4. Chuang LF, Chuang TK, Killam KF Jr, Qiu Q, Wang XR, Lin J-J, Kung H-F, Sheng W, Chao C, Yu Chuang Y (1995) Expression of kappa opioid receptors in human and monkey lymphocytes. Biochem Biophys Res Commun 209: 1003-1010
5. 5. Shiga H, Yoshino S, Nakamura H, Koiwa M (1993) Role of opioid peptide in rheumatoid arthritis: detection of methionine-enkephaline in synovial tissue. Allergy 42: 243-249
6. 6. Koiwa M, Shiga H, Nakamura H, Yoshino S (1992) Role of opioid peptide in rheumatoid arthritis: detection of β-endorphin in synovial tissue. Allergy 41: 1423-1429
7. 7. Jones AKP, Cunnigham VJ, Ha-kawa S, Fujiwara T, Luthra SK, Suva S, Derbyshire S, Jones T (1994) Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis. Br J Rheumatol 33: 909-916
8. 8. Millan MJ, Millan MH, Członkowski A, Hollt V, Pilcher CWT, Hertz A, Colpaert FC (1986) A model of chronic pain in the rats: response of multipleopioid systems to adjuvand-induced arthritis. J Neurosci 6: 899-906
9. 9. Cesselin F, Montastruc JL, Gros C, Bourgoin S, Hamon M (1980) Met-enkephalin levels and opiate receptors in the spinal cord of chronic suffering rats. Brain Res 191: 289-293
10. 10. Delay-Goyet P, Kayser V, Zajac J-M, Guilbaud G, Besson J-M, Roques BP (1989) Lack of significant changes in mu delta opioid binding sites and neutral endopeptidase EC3.4.24.11 in the brain and spinal cord of arthritic rats. Neuropharmacology 28: 1341-1348
11. 11. Sibinga NES, Goldstein A (1988) Opioid peptides and opioid receptors in cells of the immune system. Annu Rev Immunol 6: 219-249
12. 12. Rouveix B (1992) Opiates and immune function. Therapie 47: 503-512
13. 13. Millan MJ, Członkowski A, Pilcher CW, Almeida OFX, Millan MH, Colpaert FC, Herz A (1987) A model chronic pain in the rat: functional correlates of alterations in the activity of opioid systems. J Neurosci 7: 77-87
14. 14. Maekawa K, Minami M, Masuda T, Satoh M (1995) Expression of μ and κ-, but not δ-opioid receptors mRNA is enhanced in the spinal dorsal horn of the arthritic rats. Pain 64: 365-371
15. 15. Russell NJW, Jamieson A, Callen TS, Ranee MAJ (1985) Peripheral opioid effects upon neurogenic plasmap extravation and inflammation. Br J Pharmacol suppl 86: 788
16. 16. Walker JS, Hewlett CR, Nayanar V (1995) Anti-inflammatory effects of κ-opioids in adjuvant arthritis. Life Sci 57: 371-378
17. 17. Zhou J, Chen C, Xue J-C, Kunapuli S, Deriel JK, Liu-Chen L-Y (1995) Cloning of a human kappa opioid receptor from the brain. Life Sci 56: 201-207
18. 18. Ponte P, Ng SY, Engel J, Gunning P, Kedes L (1984) Evolutionary conservation in the untranslated regions on actin mRNA: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 12(3): 1687-1696
19. 19. Lansbury MJ (1958) Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis. Arthritis Rheum 1: 505-522
20. 20. Levine JD, Moskowitz MA, Basbaurn AI (1985) The contribution of neurogenic inflammation in experimental arthritis. J Immunol 135: 843-847
21. 21. Millan MJ, Colpaert FC (1991) Opioid systems in the response to inflammatory pain: sustained blockade suggests role of κ-but not μ-opioid receptors in the modulation of nociception, behaviour and pathology. Neuroscience 42: 541-553
22. 22. Prezewłocki R, Hassan AHS, Lason W, Epplen C, Herz A, Stein C (1992) Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 48: 491-500
23. 23. Binder W, Walker JS (1998) Effect of the peripherally selective κ-opioid agonist, asimadoline, on adjuvant arthritis. Br J Pharmacol 124: 647-654
24. 24. Bidlack JM, Saripalli LD, Lawrence DMP (1992) κ-opioid binding sites on a murine lymphoma cell line. Eur J Pharmacol 227: 257-265
25. 25. Wick MJ, Minnerath SR, Roy S, Ramakrishnan S, Loh HH (1996) Differential expression of opioid receptor genes in human lymphoid cell lines and peripheral blood lymphocytes. J Neuroimmunol 64: 29-36
26. 26. Sannelia MI, Petersen SIL (1997) Dual label in situ hybridization studies provide evidence that luteinizing hormone-releasing hormone neurons do not synthesize messenger ribonucleic acid for μ, κ, or δ opiate receptors. Endocrinology 138: 1667-1672
27. 27. Cunnick JE, Lysle DT, Armfield A, Rabin BS (1988) Shock-induced modulation of lymphocyte responsiveness and natural killer cell activity: differential mechanisms of induction. Brain Behav Immun 2: 102-113
28. 28. Glaser R, Rice J, Speicher CE, Stout JC, Kiecolt-Glaser JK (1986) Stress depresses interferon production concomitant with a decrease in natural killer cell activity. Behav Neurosci 100: 675-678
29. 29. Benschop RJ, Nieuwenhuis EES, Tromp EAM, Godaert GLIR, Ballieux RE, Van Doornen UP (1994) Effects of adrenergic blockade on immunologic and cardiovascular changes induced by mental stress. Circulation 89: 762-769
30. 30. Gatti Q, Cavallo R, Sartori ML, DelPonte D, Masera R, Salvarduir A, Cargnota R, Angeli A (1987) Inhibition by cortisol of human natural killer (NK) cell activity. J Steroid Biochem Mol Biol 26: 49-58
31. 31. Munck A, Guyre PM, Holbrook NJ (1984) Physiological functions of glucocorticoids and their relation to pharmacological actions. Endocr Rev 5: 25-43
32. 32. Shavit Y, Lewis JW, Terman GN, Gale RR, Liebeskind JC (1984) Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223: 188-190
33. 33. Hsueh C-M, Chen S-F, Huang H-J, Ghanta VK, Hiramoto RN (1996) Activation of μ-opioid receptors are required for the conditioned enhancement of NK cell activity. Brain Res 737: 263-268
34. 34. Gavériaux C, Peluso J, Simonin F, Laforet J, Kieffer B (1995) Identification of κ-and κ-opioid receptor transcripts in immune cells. FEBS Lett 369: 272-276
35. 35. Stein C, Hassan AHS, Prezewłocki R, Gramsch C, Peter K, Herz A (1990) Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 87: 5935-5939